About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Texas | 1,769 Studies

Clinical Trials Breast CancerTexas

Breast Cancer Clinical Trials in Texas

Find 1,769 clinical trials for breast cancer near Texas. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 141-160 of 1,769 trials

CompletedStudy of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain MetastasesVorinostat in combination with radiation therapy can be administered safely and will be tolerated in patients with brain metastases, while providing an assessment of the…NCT00838929·Philadelphia, Pennsylvania and 1 other Active not recruitingContrast-Enhanced Mammography for the Evaluation of Mammographic MicrocalcificationsThis clinical trial evaluates the added role of contrast-enhanced mammography (CEM), as well as imaging and blood biomarkers, for predicting the presence or absence of high-grade…NCT05046301·Houston, Texas

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedTrial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast CancerThis trial is designed to enroll postmenopausal patients with locally advanced or metastatic, HER2- and HR+ breast cancer not amenable to curative treatment by surgery or…NCT01528345·Chandler, Arizona and 66 others

RecruitingIdentifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.Identifying women at risk for hereditary cancer potentiates prevention, early detection or personalised treatment against cancer.NCT05649072·Houston, Texas

TerminatedA Study of LY3039478 in Participants With Advanced or Metastatic Solid TumorsThe main purpose of this study is to evaluate the safety of the study drug known as LY3039478 in combination with other anticancer agents in participants with advanced or…NCT02784795·Miami, Florida and 10 others

CompletedStudy to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected CancersThe purpose of this study was to assess the safety, tolerability, and efficacy when combining MK-3475 and INCB024360 in participants with certain cancers.NCT02178722·La Jolla, California and 23 others

RecruitingBiospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast CancerThis trial studies the biospecimen and medical data collection in creating a research tissue registry in patients with inflammatory or invasive breast cancer.NCT00477100·Gilbert, Arizona and 9 others

Active not recruiting18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in PatientsThis early phase I trial studies how well 18F-fluoroazomycin arabinoside positron emission tomography (PET)-computed tomography (CT) works in diagnosing solid tumors.NCT03168737·Houston, Texas

CompletedAmifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid TumorsRATIONALE: Amifostine may be effective in reducing pain, numbness, tingling, and other symptoms of peripheral neuropathy.NCT00078845·Decatur, Illinois and 14 others

CompletedA Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsThis research study is done to test how well different types of cancer respond to the drug called larotrectinib.NCT02576431·Palo Alto, California and 97 others

Active not recruitingAn Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast CancerThis clinical trial examines a new imaging technology, contrast-enhanced mammography, in predicting breast cancer.NCT04871139·Houston, Texas

CompletedCombined Strength Training and Functional Endurance Exercise Regimen on Cancer -Related Fatigue and Physical PerformancePrimary Objective: -Determine if a specific exercise regimen (combined strength training/functional endurance) reduces the level of fatigue among women with breast cancer while…NCT00421057·Houston, Texas

CompletedNeuropathic Pain in Survivors of Breast CancerThe objectives of this study are to: 1) describe the prevalence of neuropathic pain (NP) in breast cancer survivors and 2) to develop preliminary statistical risk models for…NCT00535067·Houston, Texas

Active not recruitingPhase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using GammapodStereotactic radiation has been implemented more than 3 decades ago, initially to radiate benign and later malignant tumors within the brain.NCT03581136·Baltimore, Maryland and 1 other

CompletedA Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast CancerThis 2 arm study compared the efficacy and safety of label dose of capecitabine (Xeloda®) to that of a lower dose of Xeloda® plus docetaxel (Taxotere®) in patients with locally…NCT00077857·Birmingham, Alabama and 93 others

Active not recruitingRadiation Therapy in Treating Patients With Stage 0-II Breast CancerThis phase II trial studies the side effects and how well radiation therapy works in treating patients with stage 0-II breast cancer.NCT01245712·Houston, Texas

CompletedDoxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamide, and paclitaxel, use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004067·Huntsville, Alabama and 148 others

TerminatedWeekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast CancerThis is a multi-center, open-label, randomized Phase II study in previously untreated patients with metastatic breast cancer to evaluate the antitumor activity and safety of…NCT00281528·Birmingham, Alabama and 39 others

CompletedAcceptability of 3D Printed Breast Models as Surgical Decision Aids for Breast Cancer TreatmentThis study is to find out the acceptability of a 3D printed breast model by patients as they consider their surgical treatment options.NCT04693364·Houston, Texas

Active not recruitingA Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)The primary purpose of this study is to determine the antitumor activity of enfortumab vedotin as measured by confirmed objective response rate (ORR) per RECIST v1.1.NCT04225117·Tucson, Arizona and 38 others

PreviousPage 8 of 89Next

Other Conditions in Texas

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma